Ginkgo Bioworks Holdings (DNA) Stock Price
$10.82 0%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
2 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Ginkgo Bioworks Holdings, AI stock picks, stock alerts and much more.
DNA AI Stock Analysis
AI stock analysis for DNA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Ginkgo Bioworks Holdings (DNA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Ginkgo Bioworks Holdings (DNA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Ginkgo Bioworks Holdings (DNA), currently trading at $10.82, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About DNA
-
Ginkgo Bioworks Holdings, Inc.
-
Symbol
DNA
-
Market
NYSE
-
Industry
Biotechnology
-
Market Cap
621.9M
Similar Stocks
 |
Novo Nordisk NVO |
$88.08 5.2% |
6 |
 |
Zymeworks ZYME |
$14.39 2.6% |
4 |
 |
Arcus Biosciences RCUS |
$11.07 3.1% |
6 |
News
DNA Alternative Data
Web Traffic
Ginkgo Bioworks Holdings receives an estimated 21526 monthly visitors to ginkgobioworks.com.
-
Web Traffic
21526
-
Change from Previous Month
44%
-
3 Month Change
66.3%
-
YoY Change
66.3%
News Mentions
Ginkgo Bioworks Holdings was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Reddit Mentions
Ginkgo Bioworks Holdings has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
100%
Twitter Followers
Ginkgo Bioworks Holdings has 34,619 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.8% over the last month.
-
Twitter Followers
34619
-
Daily Change
0%
-
1 Month Change
0.8%
-
3 Month Change
1.5%
-
YoY Change
1.5%
Facebook Engagement
Ginkgo Bioworks Holdings has engaged 11 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
11
-
Daily Change
22.2%
-
1 Month Change
38.9%
-
3 Month Change
0%
-
YoY Change
0%
Instagram Followers
Ginkgo Bioworks Holdings has 12,370 Instagram Followers on its main Instagram, down by -0.2% over the last month.
-
Instagram Followers
12370
-
Daily Change
0%
-
1 Month Change
0.2%
-
3 Month Change
0.4%
-
YoY Change
0.4%
LinkedIn Followers
96,196 are following Ginkgo Bioworks Holdings on LinkedIn, up by 1.1% over the last month.
-
LinkedIn Followers
96196
-
Daily Change
0%
-
1 Month Change
1.1%
-
3 Month Change
2.4%
Job Postings
Ginkgo Bioworks Holdings currenly has an estimated 2 open job postings.
-
Job Postings
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Ginkgo Bioworks Holdings has 954 employees, down by -3.2% over the last month.
-
LinkedIn Employees
954
-
Daily Change
0%
-
1 Month Change
3.2%
-
3 Month Change
9.2%
-
YoY Change
9.2%
Business Outlook
-
Business Outlook
18
-
Change from Previous Month
14.3%
-
3 Month Change
0%
-
YoY Change
0%
DNA Financials
DNA Key Metrics
-
Total Revenue
$89M
-
Net Income
-$56.4M
-
Earnings per Share
-$1.08
-
Free cash flow
-$118.6M
-
EBITDA
-$35.9M
-
EBITDA Ratio
-0.403499
-
Total Assets
$1.5B
DNA 2-year Revenue & Income
DNA 2-year Free Cash Flow
DNA Technicals
DNA SMA
DNA RSI
FAQ
What's the current price of Ginkgo Bioworks Holdings (DNA) Stock?
The price of an Ginkgo Bioworks Holdings (DNA) share is $10.82.
What's the market cap of Ginkgo Bioworks Holdings?
The current market cap of Ginkgo Bioworks Holdings is 621.9M.
Should I buy or sell DNA?
Ginkgo Bioworks Holdings exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Ginkgo Bioworks Holdings a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Ginkgo Bioworks Holdings stock. There are several bearish signals and market challenges that could negatively impact Ginkgo Bioworks Holdings' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Ginkgo Bioworks Holdings (DNA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Ginkgo Bioworks Holdings stock right now, as the outlook appears bearish.
What are some stocks similar to Ginkgo Bioworks Holdings (DNA) that investors often compare it to?
Ginkgo Bioworks Holdings (DNA) is often compared to similar stocks such as Novo Nordisk, Zymeworks and Arcus Biosciences.
What is the forecast for Ginkgo Bioworks Holdings' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Ginkgo Bioworks Holdings' stock price to be around $9.82 in 2026. Starting from the current price of $10.82, this represents a 9.3% change in price, indicating a bearish outlook for the stock.
How to buy Ginkgo Bioworks Holdings (DNA) Stock?
Ginkgo Bioworks Holdings stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Ginkgo Bioworks Holdings shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.